MicroRNA‑let‑7e regulates the progression and development of allergic rhinitis by targeting suppressor of cytokine signaling 4 and activating Janus kinase 1/signal transducer and activator of transcription 3 pathway

Li,Lihua; Zhang,Shaorong; Jiang,Xunshuo; Liu,Yuehui; Liu,Ke; Yang,Chunping

doi:10.3892/etm.2018.5827

MicroRNA‑let‑7e regulates the progression and development of allergic rhinitis by targeting suppressor of cytokine signaling 4 and activating Janus kinase 1/signal transducer and activator of transcription 3 pathway

Authors:
- Lihua Li
- Shaorong Zhang
- Xunshuo Jiang
- Yuehui Liu
- Ke Liu
- Chunping Yang
View Affiliations

Affiliations: Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: February 1, 2018 https://doi.org/10.3892/etm.2018.5827
Pages: 3523-3529

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the microRNA‑let‑7e (miR‑let‑7e) expression in allergic rhinitis (AR), and to investigate the underlying molecular mechanisms. miR‑let‑7e expression in the nasal mucosa of mice and patients with AR were detected. The expression levels of three inflammatory factors, including histamine, immunoglobulin E and tumor necrosis factor‑α (TNF‑α), in the blood of AR mice and in interleukin (IL)‑13‑stimulated nasal epithelial cells (NECs) were also measured. Furthermore, the target gene of miR‑let‑7e was predicted and validated using a luciferase reporter assay. The expression levels of Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3) were detected. The results demonstrated that miR‑let‑7e was downregulated in patients and mice with AR compared with the controls. In addition, the expression levels of inflammatory factors were higher in the blood of mice with AR compared with the control group, while miR‑let‑7e overexpression inhibited these levels in AR mice and IL‑13‑stimulated NECs. Furthermore, suppressor of cytokine signaling 4 (SOCS4) was revealed as a potential target gene of miR‑let‑7e and was negatively regulated by miR‑let‑7e. Overexpression of SOCS4 abrogated the anti‑inflammatory activity of miR‑let‑7e overexpression. Finally, miR‑let‑7e overexpression activated the JAK1/STAT3 signaling pathway. In conclusion, miR‑let‑7e may serve an important role in the progression and development of AR, while overexpression of miR‑let‑7e had an anti‑inflammatory effect by targeting SOCS4, which may be achieved by activation of the JAK1/STAT3 signaling pathway.

View Figures

View References

1	Suojalehto H, Toskala E, Kilpeläinen M, Majuri ML, Mitts C, Lindström I, Puustinen A, Plosila T, Sipilä J, Wolff H and Alenius H: MicroRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma. Int Forum Allergy Rhinol. 3:612–620. 2013. View Article : Google Scholar : PubMed/NCBI
2	Luo Y, Deng Y, Tao Z, Chen S, Xiao B, Ren J, Chen Z, Han J, Kong Y, Xu Y and Deng M: Regulatory effect of microRNA-135a on the Th1/Th2 imbalance in a murine model of allergic rhinitis. Exp Ther Med. 8:1105–1110. 2014. View Article : Google Scholar : PubMed/NCBI
3	Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J and Sheikh A: Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study. J Allergy Clin Immunol. 120:381–387. 2007. View Article : Google Scholar : PubMed/NCBI
4	Nihlén U, Greiff L, Montnémery P, Löfdahl CG, Johannisson A, Persson C and Andersson M: Incidence and remission of self-reported allergic rhinitis symptoms in adults. Allergy. 61:1299–1304. 2006. View Article : Google Scholar : PubMed/NCBI
5	Miadonna A, Milazzo N, Gibelli S, Salmaso C, Lorini M and Tedeschi A: Nasal response to a single antigen challenge in patients with allergic rhinitis-inflammatory cell recruitment persists up to 48 h. Clin Exp Allergy. 29:941–949. 1999. View Article : Google Scholar : PubMed/NCBI
6	Guo H, Ingolia NT, Weissman JS and Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
7	Ding H, Wu YL, Wang YX and Zhu FF: Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases. Asian Pac J Cancer Prev. 15:1675–1679. 2014. View Article : Google Scholar : PubMed/NCBI
8	O'Connell RM, Rao DS, Chaudhuri AA and Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
9	Chen RF, Huang HC, Ou CY, Hsu TY, Chuang H, Chang JC, Wang L, Kuo HC and Yang KD: MicroRNA-21 expression in neonatal blood associated with antenatal immunoglobulin E production and development of allergic rhinitis. Clin Exp Allergy. 40:1482–1490. 2010. View Article : Google Scholar : PubMed/NCBI
10	Jiang X: The emerging role of microRNAs in asthma. Mol Cell Biochem. 353:35–40. 2011. View Article : Google Scholar : PubMed/NCBI
11	Shaoqing Y, Ruxin Z, Guojun L, Zhiqiang Y, Hua H, Shudong Y and Jie Z: Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Am J Rhinol Allergy. 25:e242–e246. 2011. View Article : Google Scholar : PubMed/NCBI
12	Teng Y, Zhang R, Liu C, Zhou L, Wang H, Zhuang W, Huang Y and Hong Z: miR-143 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients by targeting IL13Rα1. Biochem Biophys Res Commun. 457:58–64. 2014. View Article : Google Scholar : PubMed/NCBI
13	Bousquet J, Lund VJ, van Cauwenberge P, Bremard-Oury C, Mounedji N, Stevens MT and El-Akkad T: Implementation of guidelines for seasonal allergic rhinitis: A randomized controlled trial. Allergy. 58:733–741. 2003. View Article : Google Scholar : PubMed/NCBI
14	Shi J, Luo Q, Chen F, Chen D, Xu G and Li H: Induction of IL-6 and IL-8 by house dust mite allergen Der p1 in cultured human nasal epithelial cells is associated with PAR/PI3K/NFkappaB signaling. ORL J Otorhinolaryngol Relat Spec. 72:256–265. 2010. View Article : Google Scholar : PubMed/NCBI
15	Peterson SM, Thompson JA, Ufkin ML, Sathyanarayana P, Liaw L and Congdon CB: Common features of microRNA target prediction tools. Front Genet. 5:232014. View Article : Google Scholar : PubMed/NCBI
16	Shi H, Chen J, Li Y, Li G, Zhong R, Du D, Meng R, Kong W and Lu M: Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma. Oncotarget. 7:21579–21590. 2016.PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, et al: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 408:86–89. 2000. View Article : Google Scholar : PubMed/NCBI
19	Iliopoulos D, Hirsch HA and Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell Transformation. Cell. 139:693–706. 2011. View Article : Google Scholar
20	Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A and Ghosh B: Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol. 128:1077–1085.e1-10. 2011. View Article : Google Scholar : PubMed/NCBI
21	Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science. 282:2258–2261. 1998. View Article : Google Scholar : PubMed/NCBI
22	Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D and Nicola NA: Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA. 95:pp. 114–119. 1998; View Article : Google Scholar : PubMed/NCBI
23	Jin HJ, Shao JZ, Xiang LX, Wang H and Sun LL: Global identification and comparative analysis of SOCS genes in fish: Insights into the molecular evolution of SOCS family. Mol Immunol. 45:1258–1268. 2008. View Article : Google Scholar : PubMed/NCBI
24	Kedzierski L, Linossi EM, Kolesnik TB, Day EB, Bird NL, Kile BT, Belz GT, Metcalf D, Nicola NA, Kedzierska K and Nicholson SE: Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection. PLoS Pathog. 10:e10041342014. View Article : Google Scholar : PubMed/NCBI
25	Galic S, Sachithanandan N, Kay TW and Steinberg GR: Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J. 461:177–188. 2014. View Article : Google Scholar : PubMed/NCBI
26	O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, Mcinnes IB and Laurence A: The JAK-STAT pathway: Impact on human disease and therapeutic intervention. Ann Rev Med. 66:311–328. 2015. View Article : Google Scholar : PubMed/NCBI
27	Aaronson DS and Horvath CM: A road map for those who don't know JAK-STAT. Science. 296:1653–1655. 2002. View Article : Google Scholar : PubMed/NCBI
28	Krebs DL and Hilton DJ: SOCS: Physiological suppressors of cytokine signaling. J Cell Sci. 113:2813–2819. 2000.PubMed/NCBI
29	Darnell JE Jr: STATs and gene regulation. Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
30	Kessler DS, Veals SA, Fu XY and Levy DE: Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev. 4:1753–1765. 1990. View Article : Google Scholar : PubMed/NCBI
31	Kim OS, Park EJ, Joe EH and Jou I: JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem. 277:40594–40601. 2002. View Article : Google Scholar : PubMed/NCBI
32	Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2:410–416. 2002. View Article : Google Scholar : PubMed/NCBI